RANI
NASDAQ · Pharmaceuticals
Rani Therapeutics Holdings-A
$0.77
-0.01 (-1.01%)
Open$0.79
Previous Close$0.78
Day High$0.83
Day Low$0.77
52W High$3.87
52W Low$0.39
Volume—
Avg Volume702.6K
Market Cap106.69M
P/E Ratio—
EPS$-0.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+4,696.6% upside
Current
$0.77
$0.77
Target
$37.15
$37.15
$30.65
$37.15 avg
$44.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.41M | 4.04M | 51.04M |
| Net Income | -61,920,527 | -66,060,306 | 8.38M |
| Profit Margin | -1,817.1% | -1,726.2% | 16.4% |
| EBITDA | -79,253,307 | -89,249,219 | 12.88M |
| Free Cash Flow | — | — | 6.14M |
| Rev Growth | -15.6% | -15.6% | +13.5% |
| Debt/Equity | — | — | 0.99 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |